{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:19:07Z","timestamp":1790540347264,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ymgme.2025.109081","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:19:06Z","timestamp":1741695546000},"page":"109081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acid sphingomyelinase deficiency: Laboratory diagnosis, genetic and epidemiologic aspects of a 50-year French cohort"],"prefix":"10.1016","volume":"145","author":[{"given":"Roseline","family":"Froissart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Pettazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Levade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie T.","family":"Vanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109081_bb0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.beem.2014.10.002","article-title":"Types A and B Niemann-Pick disease","volume":"29","author":"Schuchman","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0015","article-title":"The impact of sphingomyelin on the pathophysiology and treatment response to olipudase alfa in acid sphingomyelinase deficiency","volume":"2","author":"Kumar","year":"2024","journal-title":"Genet. Med. Open"},{"key":"10.1016\/j.ymgme.2025.109081_bb0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1073\/pnas.55.2.366","article-title":"The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae","volume":"55","author":"Brady","year":"1966","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2025.109081_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-2275(20)40138-5","article-title":"Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease","volume":"8","author":"Schneider","year":"1967","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2025.109081_bb0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.155.3758.86","article-title":"Diagnosis of Gaucher\u2019s disease and Niemann-Pick disease with small samples of venous blood","volume":"155","author":"Kampine","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2025.109081_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195802000-00001","article-title":"Niemann-Pick disease: a review of eighteen patients","volume":"37","author":"Crocker","year":"1958","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2025.109081_bb0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10545-005-0105-y","article-title":"A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A\/B, with specificity of natural sphingomyelinase substrate","volume":"28","author":"van Diggelen","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0888-7543(92)90366-Z","article-title":"Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1)","volume":"12","author":"Schuchman","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2025.109081_bb0050","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1016\/S0021-9258(18)93007-3","article-title":"Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs","volume":"266","author":"Schuchman","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109081_bb0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13023-023-02686-6","article-title":"Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types A, B and A\/B)","volume":"18","author":"Geberhiwot","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0060","first-page":"55","article-title":"Improved sensitivity of an acid sphingomyelinase activity assay using a C6:0 sphingomyelin substrate","volume":"3","author":"Chuang","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109081_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2013.11.012","article-title":"Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients","volume":"111","author":"Chuang","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","article-title":"A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease","volume":"10","author":"Giese","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clinbiochem.2015.03.007","article-title":"LC-MS\/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases","volume":"48","author":"Klinke","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2025.109081_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.107263","article-title":"Acid sphingomyelinase deficiency: epidemiologic and genetic aspects of a French cohort 1974-2021","volume":"138","author":"Pettazzoni","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0085","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1515\/bchm2.1971.352.2.1058","article-title":"A simple chemical method for labelling phosphatidylcholine and sphingomyelin in the choline moiety","volume":"352","author":"Stoffel","year":"1971","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"10.1016\/j.ymgme.2025.109081_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(79)90396-6","article-title":"The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates","volume":"92","author":"Svennerholm","year":"1979","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109081_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0009-8981(80)90309-5","article-title":"Sphingomyelinase activities of various human tissues in control subjects and in Niemann-Pick disease - development and evaluation of a microprocedure","volume":"106","author":"Vanier","year":"1980","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109081_bb0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","article-title":"Pilot study of newborn screening for six lysosomal storage diseases using tandem mass spectrometry","volume":"118","author":"Elliott","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1023\/A:1005367328003","article-title":"Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase","volume":"20","author":"Young","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181700","article-title":"LC-MS\/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: a novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease","volume":"12","author":"Pettazzoni","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2025.109081_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cca.2014.07.010","article-title":"A new simple and rapid LC-ESI-MS\/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease","volume":"437","author":"Boenzi","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109081_bb0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01247328","article-title":"Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa","volume":"92","author":"Vanier","year":"1993","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1399-0004.1985.tb00409.x","article-title":"Niemann-Pick disease type B: first-trimester prenatal diagnosis on chorionic villi and biochemical study of a foetus at 12 weeks of development","volume":"28","author":"Vanier","year":"1985","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-0004.1985.tb00180.x","article-title":"Biochemical studies in Niemann-Pick disease. III. In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease","volume":"27","author":"Vanier","year":"1985","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2018.11.014","article-title":"Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)","volume":"126","author":"Wasserstein","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0145","unstructured":"M. Wasserstein, E. Schuchman, Acid Sphingomyelinase Deficiency, GeneReviews\u00ae. [Internet]. Initial posting: 2006; last update: April 27, 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1370\/."},{"key":"10.1016\/j.ymgme.2025.109081_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0925-4439(95)00050-E","article-title":"A novel polymorphism in the human acid sphingomyelinase gene due to size variation of the signal peptide region","volume":"1270","author":"Wan","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2025.109081_bb0155","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1159\/000366345","article-title":"Secretion of acid sphingomyelinase is affected by its polymorphic signal peptide","volume":"34","author":"Rhein","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ymgme.2025.109081_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13023-024-03234-6","article-title":"Acid sphingomyelinase deficiency in France: a retrospective survival study","volume":"19","author":"Mauhin","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0165","article-title":"Survival of patients with chronic acid sphingomyelinase deficiency (ASMD) in the United States: a retrospective chart review study","volume":"38","author":"Pulikottil-Jacob","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109081_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108892","article-title":"When technology improves diagnosis: incidental discovery of ASMD in patients suspected with Gaucher disease","volume":"144","author":"Pettazzoni","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12789","article-title":"Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: a first step toward treatment criteria","volume":"48","author":"Eskes","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0180","first-page":"330","article-title":"Acid sphingomyelinase deficiency and Gaucher disease in adults: similarities and differences in two macrophage storage disorders","volume":"65","author":"Eskes","year":"2024","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109081_bb0185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0006-291X(82)80004-1","article-title":"Metabolism of sphingomyelin by intact cultured fibroblasts: differentiation of Niemann-Pick disease type A and B","volume":"105","author":"Beaudet","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2025.109081_bb0190","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1471-4159.1994.63031060.x","article-title":"Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells","volume":"63","author":"Graber","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2025.109081_bb0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0005-2760(83)90084-X","article-title":"Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases","volume":"754","author":"Kudoh","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2025.109081_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-005-5671-5","article-title":"Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study","volume":"28","author":"Pavlu-Pereira","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13023-022-02573-6","article-title":"Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1","volume":"17","author":"Dardis","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13023-023-02797-0","article-title":"Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency","volume":"18","author":"Di Rocco","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0215","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/gim.2017.7","article-title":"Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency","volume":"19","author":"McGovern","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109081_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107563","article-title":"Importance to include differential diagnostics for acid sphingomyelinase deficiency (ASMD) in patients suspected to have to Gaucher disease","volume":"139","author":"Oliva","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ab.2017.02.019","article-title":"Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A\/B and C diseases","volume":"525","author":"Kuchar","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2025.109081_bb0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13023-019-1029-1","article-title":"Chronic visceral acid sphingomyelinase deficiency (Niemann-Pick disease type B) in 16 Polish patients: long-term follow-up","volume":"14","author":"Lipinski","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s13023-022-02560-x","article-title":"Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency","volume":"17","author":"Kubaski","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0240","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1515\/cclm-2018-1301","article-title":"Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study","volume":"57","author":"Polo","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2025.109081_bb0245","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2025.109081_bb0250","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2016.06.004","article-title":"Diagnostic tests for Niemann-Pick disease type C (NP-C): a critical review","volume":"118","author":"Vanier","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0255","article-title":"Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency","volume":"28","author":"Breilyn","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109081_bb0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mam.2009.02.005","article-title":"Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis","volume":"30","author":"Brown","year":"2009","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ymgme.2025.109081_bb0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1022501702403","article-title":"Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B","volume":"24","author":"Rodriguez-Lafrasse","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2025.109081_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107800","article-title":"PPCS, the biomarker with the best clinical utility for Niemann-Pick disease type B?","volume":"141","author":"Cooper","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0275","article-title":"Case report: two years of compassionate use with Olipudase-alfa in a child with neurovisceral acid sphingomyelinase deficiency","volume":"12","author":"Deodato","year":"2024","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109081_bb0280","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.gim.2022.03.021","article-title":"A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: one-year results","volume":"24","author":"Wasserstein","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109081_bb0285","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13023-023-02983-0","article-title":"Continued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of the ASCEND trial","volume":"18","author":"Wasserstein","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108893","article-title":"Kinetic evolution of plasma biomarkers in acid sphingomyelinase deficiency patients under enzyme replacement therapy: a French experience","volume":"144","author":"Pettazzoni","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0295","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10545-006-0363-3","article-title":"Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A\/B and C","volume":"29","author":"Ries","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0300","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1073\/pnas.88.9.3748","article-title":"Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients","volume":"88","author":"Levran","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2025.109081_bb0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/humu.1380020414","article-title":"Type A Niemann-Pick disease: a frameshift mutation in the acid sphingomyelinase gene (fsP330) occurs in Ashkenazi Jewish patients","volume":"2","author":"Levran","year":"1993","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2025.109081_bb0310","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood.V80.8.2081.2081","article-title":"Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients","volume":"80","author":"Levran","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2025.109081_bb0315","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1172\/JCI115380","article-title":"Niemann-Pick type B disease. Identification of a single codon deletion in the acid sphingomyelinase gene and genotype\/phenotype correlations in type A and B patients","volume":"88","author":"Levran","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2025.109081_bb0320","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1086\/345074","article-title":"The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype\/phenotype correlations","volume":"71","author":"Simonaro","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0325","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1399-0004.2003.00025.x","article-title":"The R608del mutation in the acid sphingomyelinase gene (SMPD1) is the most prevalent among patients from gran Canaria Island with Niemann-Pick disease type B","volume":"63","author":"Fernandez-Burriel","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0330","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01800485","article-title":"A new variant of sphingomyelinase deficiency (Niemann-Pick): visceromegaly, minimal neurological lesions and low in vivo degradation rate of sphingomyelin","volume":"9","author":"Elleder","year":"1986","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0335","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1023\/A:1005387932546","article-title":"Two novel mutations in patients with atypical phenotypes of acid sphingomyelinase deficiency","volume":"20","author":"Pavlu","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0340","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2003-44668","article-title":"Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K","volume":"34","author":"Harzer","year":"2003","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2025.109081_bb0345","article-title":"Acid sphingomyelinase deficiency: the clinical spectrum of 2 patients who carry the Q294K mutation and diagnostic challenges","volume":"32","author":"Blumlein","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2025.109081_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1158108","article-title":"Case report: the spectrum of SMPD1 pathogenic variants in Hungary","volume":"14","author":"Molnar","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00735404","article-title":"A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate","volume":"17","author":"Sperl","year":"1994","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0360","first-page":"1343","article-title":"Molecular analysis of the acid sphingomyelinase deficiency in a family with an intermediate form of Niemann-Pick disease","volume":"56","author":"Ferlinz","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0365","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/brain\/awm026","article-title":"Highly variable neural involvement in sphingomyelinase-deficient Niemann-Pick disease caused by an ancestral gypsy mutation","volume":"130","author":"Mihaylova","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2025.109081_bb0370","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","article-title":"Acid sphingomyelinase (Asm) deficiency patients in the Netherlands and Belgium: disease spectrum and natural course in attenuated patients","volume":"107","author":"Hollak","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109081_bb0375","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/humu.21018","article-title":"Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients","volume":"30","author":"Rodriguez-Pascau","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2025.109081_bb0380","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/cge.12076","article-title":"Identification of seven novel SMPD1 mutations causing Niemann-Pick disease types A and B","volume":"84","author":"Irun","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0385","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2025.109081_bb0390","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/humu.9263","article-title":"Acid sphingomyelinase: identification of nine novel mutations among Italian Niemann Pick type B patients and characterization of in vivo functional in-frame start codon","volume":"24","author":"Pittis","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2025.109081_bb0395","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13023-021-01842-0","article-title":"Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation","volume":"16","author":"McGovern","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0400","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02306-2020","article-title":"Confocal LASER endomicroscopy in Niemann-Pick disease type B","volume":"57","author":"Villeneuve","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ymgme.2025.109081_bb0405","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ppul.20725","article-title":"Lung disease in Niemann-Pick disease","volume":"42","author":"Guillemot","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2025.109081_bb0410","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13023-024-03174-1","article-title":"A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany","volume":"19","author":"Mengel","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0415","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ejpn.2017.07.015","article-title":"Limited benefits of presymptomatic cord blood transplantation in neurovisceral acid sphingomyelinase deficiency (ASMD) intermediate type","volume":"21","author":"Mercati","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2025.109081_bb0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/humu.9258","article-title":"Screening of 25 Italian patients with Niemann-Pick A reveals fourteen new mutations, one common and thirteen private, in SMPD1","volume":"24","author":"Ricci","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2025.109081_bb0425","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/ajmg.a.37817","article-title":"Spectrum of SMPD1 mutations in Asian-Indian patients with acid sphingomyelinase (ASM)-deficient Niemann-Pick disease","volume":"170","author":"Ranganath","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2025.109081_bb0430","first-page":"1475","article-title":"Clinical and biochemical study of some hereditary metabolic diseases with nervous system lesions","volume":"71","author":"Gusev","year":"1971","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.ymgme.2025.109081_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167260","article-title":"ASM variants in the spotlight: a structure-based atlas for unraveling pathogenic mechanisms in lysosomal acid sphingomyelinase","volume":"1870","author":"Scrima","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1445-5994.2005.01013.x","article-title":"Clinical findings in Niemann-Pick disease type B","volume":"36","author":"Mussig","year":"2006","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ymgme.2025.109081_bb0445","first-page":"117","article-title":"Cirrhosis and liver failure: expanding phenotype of acid sphingomyelinase-deficient Niemann-Pick disease in adulthood","volume":"15","author":"Lidove","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109081_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1391936","article-title":"Case report: clinical, imaging, and genetic characteristics of type B Niemann-Pick disease combined with Segawa syndrome diagnosed via dual gene sequencing","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0455","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0460","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/humu.24192","article-title":"Clinical, biochemical, and genotype-phenotype correlations of 118 patients with Niemann-Pick disease types A\/B","volume":"42","author":"Hu","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2025.109081_bb0465","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in the Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109081_bb0470","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","article-title":"The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations","volume":"33","author":"Poupetova","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0475","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2025.109081_bb0480","article-title":"Prevalence of lysosomal storage disorders in Australia from 2009 to 2020","volume":"19","author":"Chin","year":"2022","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.ymgme.2025.109081_bb0485","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/jimd.12780","article-title":"Newborn screening for acid sphingomyelinase deficiency in Illinois: a single center\u2019s experience","volume":"47","author":"Hickey","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109081_bb0490","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/ijns10040079","article-title":"Newborn screening for acid sphingomyelinase deficiency: prevalence and genotypic findings in Italy","volume":"10","author":"Gragnaniello","year":"2024","journal-title":"Int. J. Neonatal Screen"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:36:54Z","timestamp":1771558614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1096719225000721"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109081","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acid sphingomyelinase deficiency: Laboratory diagnosis, genetic and epidemiologic aspects of a 50-year French cohort","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109081"}}